My Google Page Rank

FDA probes if Dengvaxia reached Zambo

PDFPrintE-mail

The Food and Drugs Administration (FDA) is checking whether the Dengvaxia vaccine had been sold and distributed by some medical supply companies operating in Zamboanga City.

This, after studies showed that the dengue vaccine could worsen the disease in some cases.

This was the reason why the DFA has ordered the French company Sanofi to stop selling and marketing the product in the Philippines because of side effects, especially on the immunization of people who have not been afflicted with dengue.

The FDA said it is closely coordinating with the Department of Health (DOH) for any adverse reaction that may be reported by recipients of Dengvaxia.

It would be recalled that Sanofi had earlier advised against prescribing the vaccine to those who have not contracted dengue, as it may cause severe diseases in the long run.

The City Health Office disclosed that the vaccine has not reached the city and assured that no children have been immunized with Dengvaxia. (BND)




Related news items:
Newer news items:
Older news items:

Add comment


Security code
Refresh